| Aarti Pharmalabs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543748 |
NSE Symbol : AARTIPHARM |
P/E(TTM) : 27.98 |
|
ISIN Demat : INE0LRU01027 |
Div & Yield% : 0.66 |
EPS(TTM) : 26.97 |
|
Book Value(₹) : 210.00 |
Market Cap(₹Cr) : 6,841.60 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 417.29 | 375.31 | 529.62 | 470.95 | 377.29 | 393.49 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 417.29 | 375.31 | 529.62 | 470.95 | 377.29 | 393.49 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.15 | 1.60 | -2.51 | 11.94 | 2.95 | 2.11 |
| Total Income | 420.44 | 376.91 | 527.12 | 482.88 | 380.24 | 395.60 |
| Total Expenditure | 343.31 | 280.18 | 386.50 | 355.96 | 292.52 | 309.83 |
| PBIDT | 77.13 | 96.73 | 140.62 | 126.93 | 87.72 | 85.77 |
| Interest | 10.66 | 6.79 | 6.29 | 9.70 | 5.39 | 4.25 |
| PBDT | 66.47 | 89.93 | 134.33 | 117.22 | 82.33 | 81.52 |
| Depreciation | 24.77 | 22.76 | 20.83 | 21.04 | 18.89 | 18.29 |
| Tax | 2.20 | 12.62 | 14.84 | 17.51 | 12.79 | 11.57 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 8.57 | 3.33 | 9.82 | 5.15 | 2.80 | 4.51 |
| Reported Profit After Tax | 30.93 | 51.22 | 88.85 | 73.52 | 47.84 | 47.14 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 30.93 | 51.22 | 88.85 | 73.52 | 47.84 | 47.14 |
| EPS (Unit Curr.) | 3.41 | 5.65 | 9.80 | 8.11 | 5.28 | 5.20 |
| EPS (Adj) (Unit Curr.) | 3.41 | 5.65 | 9.80 | 8.11 | 5.28 | 5.20 |
| Calculated EPS (Unit Curr.) | 3.41 | 5.65 | 9.80 | 8.11 | 5.28 | 5.20 |
| Calculated EPS (Adj) (Unit Curr.) | 3.41 | 5.65 | 9.80 | 8.11 | 5.28 | 5.20 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.65 | 22.61 | 39.21 | 32.45 | 21.11 | 20.81 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.65 | 22.61 | 39.21 | 32.45 | 21.11 | 20.81 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 50.00 | 0.00 | 0.00 |
| Equity | 45.32 | 45.32 | 45.32 | 45.31 | 45.31 | 45.31 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 18.48 | 25.77 | 26.55 | 26.95 | 23.25 | 21.80 |
| PBDTM(%) | 15.93 | 23.96 | 25.36 | 24.89 | 21.82 | 20.72 |
| PATM(%) | 7.41 | 13.65 | 16.78 | 15.61 | 12.68 | 11.98 |